Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Key Metrics
As of 2025• vs 2024
Per Share
Revenue/Share
$46.94+9.7%
Net Income/Share
$15.46+843.3%
Operating CF/Share
$0.00
Free CF/Share
$0.00
Cash/Share
$25.84+8.8%
Book Value/Share
$73.00+14.6%
Tangible Book/Share
$67.08+19.2%
Equity/Share
$73.00+14.6%
Interest Debt/Share
$14.49+109.7%
Valuation
Market Cap
$115.92B+11.8%
Enterprise Value
P/E Ratio$119.62B+18.6%
29.32+115.1%
P/S Ratio9.66+2.7%
P/OCF Ratio
0.00
P/FCF Ratio
P/B Ratio0.00
6.21-1.7%
P/TB Ratio
EV/Sales6.21-1.7%
9.97+8.9%
EV/EBITDA
25.52-87.7%
Profitability
Earnings Yield3.41%+760.2%
FCF Yield0.00%
ROE21.18%+748.9%
ROIC18.32%+595.7%
Return on Tangible Assets16.38%+730.7%
Capital Allocation
CapEx/OCF
0.00%
CapEx/Revenue
0.00%
CapEx/Depreciation
0.00
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity0.20+85.6%
Debt/Assets0.14+85.5%
Net Debt/EBITDA
Current Ratio0.79+113.6%
2.90+7.8%
Interest Coverage352.44x+4730.5%
Income Quality0.00
Efficiency
Days Sales Outstanding
62 days+17.1%
Days Payables Outstanding
768 days+679.9%
Days Inventory
377 days+31.3%
Receivables Turnover
5.85x-14.6%
Payables Turnover
0.48x-87.2%
Inventory Turnover
0.97x-23.8%
Special Valuations
Graham Number
$159.35
Graham Net-Net
$7.88+12.5%